Lv5
914 积分 2022-12-01 加入
A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in Subjects with Functional Dyspepsia
2天前
已完结
A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT)
2天前
已完结
A Randomized Study to Evaluate the Effect of an Inclisiran First Implementation Strategy vs Usual Care in Patients with ASCVD and Elevated Low-density Lipoprotein Cholesterol: Rationale and Design of the VICTORION-INITIATE Trial
2天前
求助中
† A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran with Usual Care vs Usual Care Alone in Patients with Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of the VICTORION-INCEPTION trial
2天前
已完结
A Randomized Study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidemia on Background Statin: Primary Results of the BERSON Clinical Trial
2天前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
2天前
已完结
A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus
2天前
已完结
P3.18.30 A Phase II Clinical Study of Tafolecimab Combined With Sintilimab in the Treatment of Advanced NSCLC Who Failed the Previous Immunotherapy
2天前
待确认
A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects
2天前
已完结
A phase 1 study to evaluate the safety and LDL cholesterol–lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9
2天前
已完结
皖公网安备34019202002308
